Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Tempus xR
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Tempus
Type:
Laboratory Developed Test
Related tests:
‹
Tempus xT Assay (1)
Immune Profile Score Algorithmic Test
PurIST℠ Test
Tempus HLA-LOH assay
Tempus HRD test
Tempus TO
Tempus xE
Tempus xF Assay
Tempus xF Monitor assay
Tempus xF+ Panel
Tempus xG
Tempus xG+
Tempus xM
Tempus xO assay
Tempus xT Assay (1)
Immune Profile Score Algorithmic Test
PurIST℠ Test
Tempus HLA-LOH assay
Tempus HRD test
Tempus TO
Tempus xE
Tempus xF Assay
Tempus xF Monitor assay
Tempus xF+ Panel
Tempus xG
Tempus xG+
Tempus xM
Tempus xO assay
›
Details
Evidence
News
Tempus xR is a whole transcriptome panel for solid tumors, reporting clinically relevant fusions for more than 100 targeted genes, as well as altered splicing for MET Exon 14 and EGFRvIII.
Cancer:
Solid Tumor
Gene:
EGFR (Epidermal growth factor receptor), MET (MET proto-oncogene, receptor tyrosine kinase)
EGFR (Epidermal growth factor receptor), MET (MET proto-oncogene, receptor tyrosine kinase)
Method:
Next-Generation Sequencing (NGS)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login